New roles for old proteins in adult CNS axonal regeneration

Current Opinion in Neurobiology

Volumn 13, Issue 1, 2003, Pages 133-139

  Spencer, Timothy ^a   Domeniconi, Marco ^a   Cao, Zixuan ^a   Filbin, Marie T ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; PROTEIN; PROTEOGLYCAN;

ADULTHOOD; BINDING AFFINITY; CENTRAL NERVOUS SYSTEM; NERVE FIBER REGENERATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; REVIEW;

EID: 0037322357     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(03)00012-6     Document Type: Review

References (41)

1. David S., Aguayo A.J. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science. 214:1981;931-933.
2. McKeon R.J., Schreiber R.C., Rudge J.S., Silver J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11:1991;3398-3411.
3. Niederost B.P., Zimmermann D.R., Schwab M.E., Bandtlow C.E. Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans. J. Neurosci. 19:1999;8979-8989.
4. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 416:2002;636-640 Following dorsal column lesioning, intrathecal delivery of chondroitinase ABC - an enzyme that removes glycosaminoglycan from CSPG molecules - results in improved regeneration of both sensory and motor projections. Electrophysiological and functional recovery, however, was limited to motor pathways and the distance that regeneration took place over was relatively short.
5. Berry M: Post-injury myelin-breakdown products inhibit axonal growth: an hypothesis to explain the failure of axonal regeneration in the mammalian central nervous system. Bibl Anat 1982:1-11.
6. Caroni P., Schwab M.E. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1:1988;85-96.
7. Bregman B.S., Kunkel-Bagden E., Schnell L., Dai H.N., Gao D., Schwab M.E. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 378:1995;498-501.
8. Caroni P., Schwab M.E. Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J. Cell. Biol. 106:1988;1281-1288.
9. Mukhopadhyay G., Doherty P., Walsh F.S., Crocker P.R., Filbin M.T. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron. 13:1994;757-767.
10. McKerracher L., David S., Jackson D.L., Kottis V., Dunn R.J., Braun P.E. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron. 13:1994;805-811.
11. Everly J.L., Brady R.O., Quarles R.H. Evidence that the major protein in rat sciatic nerve myelin is a glycoprotein. J. Neurochem. 21:1973;329-334.
12. Trapp B.D. Myelin-associated glycoprotein. Location and potential functions. Ann. NY Acad. Sci. 605:1990;29-43.
13. Willison H.J., Ilyas A.I., O'Shannessy D.J., Pulley M., Trapp B.D., Quarles R.H. Myelin-associated glycoprotein and related glycoconjugates in developing cat peripheral nerve: a correlative biochemical and morphometric study. J. Neurochem. 49:1987;1853-1862.
14. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:2000;434-439.
15. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 403:2000;439-444.
16. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., Walsh F.S. Inhibitor of neurite outgrowth in humans. Nature. 403:2000;383-384.
17. GrandPre T., Li S., Strittmatter S.M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature. 417:2002;547-551 The authors identify an antagonist of NgR, peptide NEP1-40, that binds to the receptor with high affinity. Application of this peptide in vitro improves axonal extension on myelin in culture and, after intrathecal delivery, results in axonal sprouting and regeneration following a dorsal column lesion. These findings provide the basis for a potential therapeutic strategy for inducing regeneration after injury.
18. Huber A.B., Schwab M.E. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biol. Chem. 381:2000;407-419.
19. Mikol D.D., Stefansson K. A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes. J. Cell. Biol. 106:1988;1273-1279.
20. Kottis V., Thibault P., Mikol D., Xiao Z.C., Zhang R., Dergham P., Braun P.E. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem. 82:2002;1566-1569 The authors show that the major component of the protein fraction that inhibits neurite outgrowth, arretin, is OMgp. Recombinant OMgp can inhibit neurite outgrowth from NG108 and PC12 cells as well as from rat retinal ganglion neurons in vitro.
21. Wang K.C., Koprivica V., Kim J.A., Sivasankaran R., Guo Y., Neve R.L., He Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 417:2002;941-944 The authors show that GPI-linked proteins that are released from CNS myelin by PtdIns-PLC can induce the collapse of neuronal growth cones, and of these proteins, the main inhibitory agent is OMgp. In addition, OMgp is shown to be a ligand for NgR. These findings provide further evidence that OMgp is a myelin-associated inhibitor. They show for the first time, that NgR is a receptor for more than one myelin inhibitor.
22. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 409:2001;341-346 This study identifies NgR as the neuronal receptor for Nogo-66. This is the first receptor identified for a myelin inhibitor. As NgR is GPI-linked, it must have a partner that transduces the signal across the membrane.
23. Wang X., Chun S.J., Treloar H., Vartanian T., Greer C.A., Strittmatter S.M. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J. Neurosci. 22:2002;5505-5515 The localizations of the proteins Nogo-A and NgR indicate that Nogo-A is expressed primarily in the periaxonal membrane of myelin and that NgR is present throughout axons. In addition, analysis of protein levels indicate a moderate upregulation of Nogo-A expression and no change in the expression of NgR after spinal cord transection. These findings are consistent with the hypothesis that NgR is the functional neuronal ligand for the inhibitory effects of Nogo-A following injury.
24. Vinson M., Strijbos P.J., Rowles A., Facci L., Moore S.E., Simmons D.L., Walsh F.S. Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition. J. Biol. Chem. 276:2001;20280-20285.
25. Vyas A.A., Patel H.V., Fromholt S.E., Heffer-Lauc M., Vyas K.A., Dang J., Schachner M., Schnaar R.L. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc. Natl. Acad. Sci. USA. 99:2002;8412-8417.
26. Tang S., Shen Y.J., DeBellard M.E., Mukhopadhyay G., Salzer J.L., Crocker P.R., Filbin M.T. Myelin-associated glycoprotein interacts with neurons via a sialic acid binding site at ARG118 and a distinct neurite inhibition site. J. Cell. Biol. 138:1997;1355-1366.
27. Liu B.P., Fournier A., GrandPre T., Strittmatter S.M. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science. 297:2002;1190-1193 Screening of a cDNA expression library with soluble NgR and subsequent sequence analysis of the binding partners resulted in the finding that MAG is an NgR ligand. Removal of the NgR with PI-PLC or application of a competitive inhibitor (NgR-ectodomain) abrogates the ability of MAG to induce growth cone collapse and inhibit neurite outgrowth, and ectopic expression of NgR confers sensitivity to MAG to normally unresponsive neurons. These findings provide the first evidence that NgR, the receptor that mediates the Nogo-66 inhibition, also mediates the inhibitory effects of MAG.
28. Domeniconi M., Cao Z., Spencer T., Sivasankaran R., Wang K., Nikulina E., Kimura N., Cai H., Deng K., Gao Y.et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron. 35:2002;283-290 The authors also provide evidence that NgR is the function-mediating receptor for MAG. They achieve this via cell binding assays and coimmunoprecipitation of NgR from transfected CHO cells or primary neurons. Use of a dominant-negative form of NgR, removal of the NgR with PtdIns-PLC, or application of competitive inhibitors abrogates the ability of MAG to inhibit neurite outgrowth in vitro. These findings further support the hypothesis that NgR binds MAG and mediates its inhibitory effects on axonal outgrowth.
29. NTR.
30. NTR.
31. Lehmann M., Fournier A., Selles-Navarro I., Dergham P., Sebok A., Leclerc N., Tigyi G., McKerracher L. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J. Neurosci. 19:1999;7537-7547.
32. NTR inhibitory complex to encourage axonal regeneration.
33. Winton M.J., Dubreuil C.I., Lasko D., Leclerc N., McKerracher L. Characterization of new cell permeable C3-like proteins that inactivate Rho and stimulate neurite outgrowth on inhibitory substrates. J. Biol. Chem. 277:2002;32820-32829.
34. Cai D., Shen Y., De Bellard M., Tang S., Filbin M.T. Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron. 22:1999;89-101.
35. Song H., Ming G., He Z., Lehmann M., McKerracher L., Tessier-Lavigne M., Poo M. Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science. 281:1998;1515-1518.
36. Richardson P.M., Issa V.M. Peripheral injury enhances central regeneration of primary sensory neurones. Nature. 309:1984;791-793.
37. Richardson P.M., Verge V.M. The induction of a regenerative propensity in sensory neurons following peripheral axonal injury. J. Neurocytol. 15:1986;585-594.
38. Neumann S., Woolf C.J. Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. Neuron. 23:1999;83-91.
39. Neumann S., Bradke F., Tessier-Lavigne M., Basbaum A.I. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron. 34:2002;885-893 The authors show that the regeneration of DRG axons is vastly improved after microinjection of a cAMP analog, dibutryl-cAMP (db-cAMP), both in the CNS (dorsal column) and when the neurons are cultured on permissive or inhibitory substrates. The results demonstrate that intracellular cAMP levels may modulate the intrinsic growth state of an injured axon.
40. Qiu J., Cai D., Dai H., McAtee M., Hoffman P.N., Bregman B.S., Filbin M.T. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron. 34:2002;895-903 This study shows that after a peripheral conditioning lesion, cAMP levels in DRG cell bodies transiently increase. The authors also show that direct injection of db-cAMP into the DRG cell body without a conditioning lesion is sufficient to induce regeneration of subsequently lesioned dorsal column axons. This regeneration is of a similar extent to that seen with a conditioning lesion and provides further evidence of the importance of intracellular cAMP levels in the induction of regeneration following injury.
41. Cai D., Deng K., Mellado W., Lee J., Ratan R.R., Filbin M.T. Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron. 35:2002;711-719 The authors describe a downstream consequence of elevated cAMP, which allows axons to grow on a myelin substrate. The enzyme Arginase I (ArgI), which is key in the synthesis of polyamines, is up-regulated by cAMP. Polyamines are also elevated in response to treatment with db-cAMP. Either overexpression of ArgI or addition of polyamines is sufficient to overcome inhibition by myelin. These findings illustrate yet another downstream, therapeutic target for encouraging axonal regeneration after injury.